SIMON SAYS, LET'S TALK BUSINESS: David Dodd with GeoVax
19 gen 2023 ·
30 min. 54 sec.
Iscriviti gratuitamente
Ascolta questo episodio e molti altri. Goditi i migliori podcast su Spreaker!
Scarica e ascolta ovunque
Scarica i tuoi episodi preferiti e goditi l'ascolto, ovunque tu sia! Iscriviti o accedi ora per ascoltare offline.
Descrizione
David Dodd/GeoVax GeoVax Labs is a clinical-stage biotechnology company developing novel therapies and vaccines for cancers and many of the world's most threatening infectious diseases. The company's lead program in...
mostra di più
David Dodd/GeoVax GeoVax Labs is a clinical-stage biotechnology company developing novel therapies and vaccines for cancers and many of the world's most threatening infectious diseases. The company's lead program in oncology is a novel oncolytic solid tumor gene-directed therapy, Gedeptin®, presently in a multicenter Phase 1/2 clinical trial for advanced head and neck cancers. GeoVax's [...]
mostra meno
Informazioni
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
